Reata Pharmaceuticals (NASDAQ:RETA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Reata Pharmaceuticals beat estimated earnings by 38.14%, reporting an EPS of $-1.33 versus an estimate of $-2.15.
Revenue was down $30.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.72 which was followed by a 1.5% increase in the share price the next day.
Here's a look at Reata Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -2.31 | -2.16 | -2.08 | -2.10 |
| EPS Actual | -1.59 | -1.27 | -1.32 | -1.16 |
| Revenue Estimate | 1.63M | 2.07M | 1.25M | 1.19M |
| Revenue Actual | 934.00K | 7.39M | 2.22M | 944.00K |
To track all earnings releases for Reata Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
